Ethical considerations in presymptomatic diagnosis of autosomal dominant spinocerebellar ataxias
Introduction: Information on achieving presymptomatic diagnosis of spinocerebellar ataxia (SCA) is limited. The advent of molecular diagnosis makes it possible to identify the carriers of different diseases and has also introduced the prospect of detecting diseases even before their onset. This has...
Main Authors: | M.H. Orozco-Gutiérrez, I. Cervantes-Aragón, D. García-Cruz |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier España
2017-09-01
|
Series: | Neurología (English Edition) |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2173580817300652 |
Similar Items
-
Ophthalmic Manifestations and Genetics of the Polyglutamine Autosomal Dominant Spinocerebellar Ataxias: A Review
by: Jun Young Park, et al.
Published: (2020-08-01) -
Motor decline in clinically presymptomatic spinocerebellar ataxia type 2 gene carriers.
by: Luis Velázquez-Perez, et al.
Published: (2009-01-01) -
Missense mutations in <it>ITPR1</it> cause autosomal dominant congenital nonprogressive spinocerebellar ataxia
by: Huang Lijia, et al.
Published: (2012-09-01) -
Multimodal neurophysiological study of SCA2 and SCA3 autosomal dominant hereditary spinocerebellar ataxias
by: S. Álvarez-Paradelo, et al.
Published: (2011-01-01) -
Keys to overcoming the challenge of diagnosing autosomal recessive spinocerebellar ataxia
by: M. Arias
Published: (2019-05-01)